News
In patients greater than age 65, more than 90% of aortic stenosis involves trileaflet valves which have developed heavy calcification. [5] In these instances the calcium deposits are thought to ...
The U.S. Food and Drug Administration has approved Edwards Lifesciences' SAPIEN 3 platform, a transcatheter aortic valve ...
A complete echocardiographic evaluation for aortic stenosis requires quantitative and qualitative evaluation of LV function, structural changes in the aortic cusps, sinus of valsalva, proximal ...
Find out why staging TAVI and PCI lowers risk in complex heart cases - read the latest insights from the ASCoP registry.
14d
Medical Device Network on MSNFDA approves Edwards’ TAVR system for asymptomatic aortic stenosis patientsEdwards’ SAPIEN 3 platform becomes the first TAVR system approved by the FDA for asymptomatic severe aortic stenosis patients.
Researchers have developed cutting-edge MRI technology to diagnose a common heart problem more quickly and accurately than ever before. Aortic stenosis is a progressive and potentially fatal condition ...
The benefit of TAVR vs. clinical surveillance for patients with asymptomatic severe aortic stenosis did not vary by age. TAVR was tied to lower stroke risk in the youngest and oldest age groups.
Please provide your email address to receive an email when new articles are posted on . Electronic provider notification led to more aortic valve replacement procedures after a diagnosis of severe ...
7d
News Medical on MSNScientists develop advanced MRI technology to diagnose aortic stenosisUniversity of East Anglia scientists have developed cutting-edge MRI technology to diagnose a common heart problem more quickly and accurately than ever before.
New analysis from the EARLY TAVR trial showed patients between the age of 65 and 70 years old derived the most benefits of a ...
A new method of alerting clinical care providers holds promise for increasing treatment and improving survival for patients with severe aortic stenosis (AS), a valvular heart condition that can be ...
FDA Approves SAPIEN 3 Platform for Asymptomatic Severe Aortic Stenosis By Lori Solomon HealthDay ReporterMONDAY, May 5, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results